Small logo Subscribe to leading news on impact investing. Learn More
The Brief Originals Dealflow Signals The Impact Alpha Impact Voices Podcasts Agents of Impact Open
What's Next Capital on the Frontier Measure Better Investing in Racial Equity Beyond Trade-offs Impact en las Americas New Revivalists
Local and Inclusive Climate Finance Catalytic Capital Frontier Finance Best Practices Geographies
Slack Agent of Impact Calls Events Contribute
The Archive ImpactSpace The Accelerator Selection Tool Network Map
About Us FAQ Calendar Pricing and Payment Policy Privacy Policy Terms of Service Agreement Contact Us
Locavesting Entrepreneurship Gender Smart Return on Inclusion Good Jobs Creative economy Opportunity Zones Investing in place Housing New Schooled Well Being People on the Move Faith and investing Inclusive Fintech
Clean Energy Farmer Finance Soil Wealth Conservation Finance Financing Fish
Innovative Finance
Personal Finance Impact Management
Africa Asia Europe Latin America Middle East Oceania/Australia China Canada India United Kingdom United States
Subscribe Log In

EverlyWell raises $50 million for at-home health diagnostics

ImpactAlpha, April 17 – Austin-based EverlyWell launched in 2015 to help people stay informed about their health while cutting costs. The company makes at-home diagnostic exams that individuals can use to test for everything from food allergies to fertility to sexually transmitted diseases. The company is expanding its services to include physician consults and some prescriptions.

“EverlyWell customers tell us daily that we’ve changed their lives by providing healthcare services they otherwise wouldn’t be able to afford, access or understand,” EverlyWell founder Julia Cheek said in a statement.

EverlyWell’s $50 million funding round was backed by Goodwater Capital, Highland Capital Partners, Next Coast Ventures, NextGen Venture Partners, and SoGal Ventures. Check it out.

You might also like...